A case of rapid eyemovement sleep behavior disorder in Parkinson disease treated with sodium oxybate

JAMA Neurology

Volumn 73, Issue 1, 2016, Pages 126-127

  Liebenthal, Jennifer ^a   Valerio, Jason ^a,b   Ruoff, Chad ^a   Mahowald, Mark ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; CYPROHEPTADINE; ESZOPICLONE; MELATONIN; OXYBATE SODIUM; PRAZOSIN; RAMELTEON;

ABSENCE OF SIDE EFFECTS; ADULT; APNEA HYPOPNEA INDEX; ASSAULT; AUTOMUTILATION; BEDTIME DOSAGE; BRAIN DEPTH STIMULATION; CASE REPORT; CPAP DEVICE; DREAM ENACTMENT BEHAVIOR; DROWSINESS; DRUG DOSE TITRATION; DRUG TOLERABILITY; FOLLOW UP; HOEHN AND YAHR SCALE; HUMAN; LETTER; MALE; MEDICAL HISTORY; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; AGED; COMPLICATION; PROCEDURES; REM SLEEP BEHAVIOR DISORDER;

AGED; HUMANS; MALE; PARKINSON DISEASE; POLYSOMNOGRAPHY; REM SLEEP BEHAVIOR DISORDER; SODIUM OXYBATE;

EID: 84954225493     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.2904     Document Type: Letter

References (5)

1. Shneerson JM. Successful treatment of REM sleep behavior disorder with sodium oxybate. Clin Neuropharmacol. 2009;32(3): 158-159.
2. Aurora RN, Zak SZ, Maganti RK, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6(1): 85-95.
3. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61(8): 928-934.
4. Mysliwiec V, O'Reilly B, Polchinski J, Kwon HP, Germain A, Roth BJ. Trauma associated sleep disorder: A proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors. J Clin Sleep Med. 2014;10(10): 1143-1148.
5. OndoWG, Perkins T, Swick T, et al. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: An open-label polysomnographic study. Arch Neurol. 2008;65(10): 1337-1340.